This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Jan 6;31(1):311.

doi: 10.1093/ibd/izae241.

Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch

Tala B Shahin¹, Muhammad-Nowsherwan Kundi¹, Talha A Malik¹

Affiliations

PMID: 39437342
DOI: 10.1093/ibd/izae241

Editorial

Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch

Tala B Shahin et al. Inflamm Bowel Dis. 2025.

. 2025 Jan 6;31(1):311.

doi: 10.1093/ibd/izae241.

Authors

Tala B Shahin¹, Muhammad-Nowsherwan Kundi¹, Talha A Malik¹

Affiliation

¹ Department of Medicine-Gastroenterology, Mayo Clinic Arizona, Phoenix, AZ, USA.

PMID: 39437342
DOI: 10.1093/ibd/izae241

Erratum in

Correction to: Risankizumab Is Effective for the Management of Crohn's Disease of the Pouch.
[No authors listed] [No authors listed] Inflamm Bowel Dis. 2025 Aug 1;31(8):2328. doi: 10.1093/ibd/izae295. Inflamm Bowel Dis. 2025. PMID: 39656812 No abstract available.

No abstract available

PubMed Disclaimer

Comment on

Risankizumab Is Effective for The Management of Crohn's Disease of the Pouch.
Kayal M, Spencer EA, Smyth M, Raffals L, Qazi T, Deepak P, Beniwal-Patel P, Chang S, Higgins P, Cross RK, Anderson C, Long M, Herfarth HH, Dubinsky MC, Barnes EL. Kayal M, et al. Inflamm Bowel Dis. 2025 Mar 3;31(3):878-881. doi: 10.1093/ibd/izae164. Inflamm Bowel Dis. 2025. PMID: 39038228 Free PMC article.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.